RESEARCH CORPORATION TECHNOLOGIES INC has a total of 22 patent applications. Its first patent ever was published in 1990. It filed its patents most often in Australia and Luxembourg. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are LEIDEN UNIV MEDICAL CENTER, BACHMANN MARTIN and VEGENICS PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 21 | |
#2 | Luxembourg | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Organic fine chemistry | |
#5 | Measurement | |
#6 | Environmental technology | |
#7 | Transport |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Fermentation | |
#7 | Combinatorial chemistry | |
#8 | Climate change adaptation technologies | |
#9 | Analysing materials | |
#10 | Vehicle parts |
# | Name | Total Patents |
---|---|---|
#1 | Harris Robert H | 5 |
#2 | Gehlsen Kurt R | 4 |
#3 | Contreras Roland | 3 |
#4 | Callewaert Nico L M | 3 |
#5 | Kaigorodov Vladimir | 2 |
#6 | Lukanidin Eugene | 2 |
#7 | Bramhill David | 2 |
#8 | Geysens Steven C J | 2 |
#9 | Aggarwal Parag | 1 |
#10 | Bachmann Brian | 1 |
Publication | Filing date | Title |
---|---|---|
AU2018240029A1 | Engineered stable CH2 polypeptides | |
AU2013216943A1 | Fusion proteins comprising immunoglobulin constant domain-derived scaffolds | |
AU2012214274A1 | CH2 domain template molecules derived from rational grafting of donor loops onto CH2 scaffolds | |
AU2007207519A1 | Viable non-toxic gram negative bacteria | |
AU2005339232A1 | Hybrid 3' untranslated regions suitable for efficient protein expression in mammalian cells | |
AU4486500A | Therapeutic compositions and methods for treating tumors |